Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial on the Effect of Isatuximab to Lenaliodomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03617731
Recruitment Status : Recruiting
First Posted : August 6, 2018
Last Update Posted : March 28, 2019
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Hartmut Goldschmidt, University of Heidelberg Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2025
  Estimated Study Completion Date : December 2025